Selecta Biosciences, Inc. (Nasdaq:SELB) today announced the closing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $14.00 per share, before underwriting discounts and commissions. All of the shares of common stock in the offering were sold by Selecta Biosciences. In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock from the company at the initial public offering price, less the underwriting discounts and commissions, to cover over-allotments, if any. The company’s common stock began trading on the NASDAQ Global Market on Wednesday, June 22, 2016 under the ticker symbol “SELB.”
UBS Investment Bank and Stifel acted as joint book-running managers for the offering. Canaccord Genuity and Needham & Company acted as co-managers for the offering.